Clinical Research on Orphan Drugs

The Orphan Drug clinical exploration program provides orphan status to medicines and biologics which are defined as those intended for the treatment, forestalment or opinion of a rare complaint or situation, which is one that disturb lower than persons. We can see momentous progress in the development of treatments for rare conditions, also known as orphan medicines. Especially the agency authorized 32 new medicines and biologics with title named as orphan medicines

    Related Conference of Clinical Research on Orphan Drugs

    September 12-13, 2024

    19th International Conference on Allergic Diseases and Clinical Immunology

    Paris, France
    October 24-25, 2024

    5th International Conference on Immunology And Immunotherapy

    Zurich, Switzerland
    November 26-27, 2024

    38th International Conference on Immunology

    Madrid, Spain
    April 14-15, 2025

    12th World Congress and Exhibition on Antibiotics and Antibiotic Resistance

    Aix-en-Provence, France
    May 05-06, 2025

    6th World Congress on Neuroimmunology and Neuroinfectious Diseases

    Rome, Italy
    May 19-20, 2025

    3rd World Congress on Infectious and Contagious Disease

    Rome, Italy
    May 22-23, 2025

    6th International Conference on Immunology and Radiotherapy

    Toronto, Canada
    June 16-17, 2025

    19th International Conference on European Immunology

    Frankfurt, Germany
    August 26-27, 2025

    6th International conference on Vaccines, Vaccination and Immunization

    Aix-en-Provence, France

    Clinical Research on Orphan Drugs Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in